A detailed history of Lsv Asset Management transactions in Merck & Co., Inc. stock. As of the latest transaction made, Lsv Asset Management holds 6,015,120 shares of MRK stock, worth $590 Million. This represents 1.46% of its overall portfolio holdings.

Number of Shares
6,015,120
Previous 6,356,770 5.37%
Holding current value
$590 Million
Previous $787 Million 13.2%
% of portfolio
1.46%
Previous 1.72%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$111.15 - $128.97 $38 Million - $44.1 Million
-341,650 Reduced 5.37%
6,015,120 $683 Million
Q2 2024

Aug 06, 2024

SELL
$123.8 - $132.96 $78.1 Million - $83.9 Million
-631,010 Reduced 9.03%
6,356,770 $787 Million
Q1 2024

May 06, 2024

SELL
$113.24 - $131.95 $54.5 Million - $63.5 Million
-481,290 Reduced 6.44%
6,987,780 $922 Million
Q4 2023

Feb 06, 2024

SELL
$100.18 - $109.02 $34.6 Million - $37.6 Million
-345,130 Reduced 4.42%
7,469,070 $814 Million
Q3 2023

Nov 03, 2023

SELL
$102.95 - $114.33 $70.1 Million - $77.9 Million
-681,250 Reduced 8.02%
7,814,200 $804 Million
Q2 2023

Aug 02, 2023

SELL
$108.61 - $118.38 $74 Million - $80.7 Million
-681,670 Reduced 7.43%
8,495,450 $980 Million
Q1 2023

May 02, 2023

SELL
$102.94 - $114.86 $76.1 Million - $84.9 Million
-738,800 Reduced 7.45%
9,177,120 $976 Million
Q4 2022

Feb 08, 2023

SELL
$87.44 - $112.11 $125 Million - $160 Million
-1,425,875 Reduced 12.57%
9,915,920 $1.1 Billion
Q3 2022

Nov 07, 2022

SELL
$84.53 - $94.96 $83 Million - $93.3 Million
-982,417 Reduced 7.97%
11,341,795 $977 Million
Q2 2022

Aug 10, 2022

SELL
$83.49 - $94.64 $110 Million - $125 Million
-1,318,074 Reduced 9.66%
12,324,212 $1.12 Billion
Q1 2022

May 12, 2022

SELL
$73.51 - $82.4 $40 Million - $44.8 Million
-544,276 Reduced 3.84%
13,642,286 $1.12 Billion
Q4 2021

Jan 28, 2022

SELL
$72.28 - $90.54 $36.1 Million - $45.2 Million
-499,210 Reduced 3.4%
14,186,562 $1.09 Billion
Q3 2021

Nov 04, 2021

BUY
$71.68 - $78.83 $27.2 Million - $29.9 Million
379,681 Added 2.65%
14,685,772 $1.1 Billion
Q2 2021

Aug 04, 2021

BUY
$70.31 - $77.77 $325 Million - $360 Million
4,628,832 Added 47.83%
14,306,091 $1.11 Billion
Q1 2021

Apr 30, 2021

SELL
$68.86 - $81.11 $1.73 Million - $2.03 Million
-25,058 Reduced 0.26%
9,677,259 $746 Million
Q4 2020

Feb 08, 2021

BUY
$71.77 - $79.65 $80.2 Million - $89 Million
1,117,333 Added 13.01%
9,702,317 $794 Million
Q3 2020

Oct 23, 2020

BUY
$73.18 - $82.95 $1.87 Million - $2.12 Million
25,609 Added 0.3%
8,584,984 $712 Million
Q2 2020

Aug 05, 2020

BUY
$70.42 - $80.13 $40.4 Million - $46 Million
573,850 Added 7.19%
8,559,375 $662 Million
Q1 2020

May 07, 2020

BUY
$63.36 - $87.82 $29.4 Million - $40.8 Million
464,103 Added 6.17%
7,985,525 $614 Million
Q4 2019

Feb 10, 2020

SELL
$77.58 - $87.54 $19 Million - $21.4 Million
-244,452 Reduced 3.15%
7,521,422 $684 Million
Q3 2019

Nov 07, 2019

SELL
$76.08 - $82.93 $68.8 Million - $74.9 Million
-903,703 Reduced 10.42%
7,765,874 $654 Million
Q2 2019

Aug 08, 2019

SELL
$69.84 - $81.59 $20.5 Million - $23.9 Million
-293,077 Reduced 3.27%
8,669,577 $727 Million
Q1 2019

May 07, 2019

BUY
$69.58 - $79.36 $5.05 Million - $5.76 Million
72,600 Added 0.82%
8,962,654 $745 Million
Q4 2018

Feb 05, 2019

SELL
$65.24 - $75.71 $14 Million - $16.3 Million
-215,033 Reduced 2.36%
8,890,054 $679 Million
Q3 2018

Nov 06, 2018

SELL
$57.69 - $67.84 $28.7 Million - $33.8 Million
-497,606 Reduced 5.18%
9,105,087 $646 Million
Q2 2018

Aug 08, 2018

BUY
$50.83 - $59.72 $1.72 Million - $2.02 Million
33,899 Added 0.35%
9,602,693 $583 Million
Q1 2018

May 04, 2018

SELL
$50.96 - $59.23 $2.05 Million - $2.39 Million
-40,306 Reduced 0.42%
9,568,794 $521 Million
Q4 2017

Feb 01, 2018

SELL
$51.62 - $61.64 $17.9 Million - $21.4 Million
-346,838 Reduced 3.48%
9,609,100 $0
Q3 2017

Nov 13, 2017

BUY
$58.67 - $63.13 $584 Million - $629 Million
9,955,938
9,955,938 $637 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $248B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Lsv Asset Management Portfolio

Follow Lsv Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lsv Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Lsv Asset Management with notifications on news.